Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000999405 | SCV001156006 | likely pathogenic | not provided | 2019-03-01 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001253354 | SCV001429026 | likely pathogenic | FG syndrome 4 | 2024-07-30 | criteria provided, single submitter | clinical testing | Criteria applied: PS4_MOD,PM2,PM5,PP2 |
Kariminejad - |
RCV001814250 | SCV001755135 | likely pathogenic | Abnormality of the nervous system | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000999405 | SCV001988443 | likely pathogenic | not provided | 2023-12-13 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33090494, 30525188) |
Labcorp Genetics |
RCV003624437 | SCV004551795 | pathogenic | Intellectual disability, CASK-related, X-linked | 2023-06-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg489 amino acid residue in CASK. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 27799067, 33090494). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CASK protein function. ClinVar contains an entry for this variant (Variation ID: 810578). This missense change has been observed in individual(s) with clinical features of developmental and epileptic encephalopathy, intellectual disability, and/or seizures (PMID: 30525188; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 489 of the CASK protein (p.Arg489Gln). |